We are live on
!
Find out more
LIC
Lodestar Investment Counsel Portfolio holdings
AUM
$974M
1-Year Est. Return
13.79%
This Fund
S&P 500
This Quarter
Est. Return
+3.83%
1 Year Est. Return
+13.79%
3 Year Est. Return
+45.09%
5 Year Est. Return
+56.53%
10 Year Est. Return
–
AUM
$739M
AUM Growth
+$12.2M
(+1.7%)
Cap. Flow
-$6.79M
Cap. Flow
% of AUM
-0.92%
Top 10 Holdings %
Top 10 Hldgs %
30.3%
Holding
162
New
4
Increased
51
Reduced
65
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$1.26M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$888K |
| 3 |
Walmart Inc
WMT
|
+$844K |
| 4 |
Abbott
ABT
|
+$504K |
| 5 |
JPMorgan Chase
JPM
|
+$361K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$5.71M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$1.29M |
| 3 |
Walt Disney
DIS
|
+$976K |
| 4 |
Microsoft
MSFT
|
+$474K |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$387K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.21% |
| 2 | Financials | 14.9% |
| 3 | Industrials | 14.27% |
| 4 | Consumer Staples | 11.79% |
| 5 | Technology | 11.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UN
151
DELISTED
Unilever NV New York Registry Shares
UN
| $202K | 0.03% |
4,925
-250
| -5% | -$10.3K |
|
152
Weyerhaeuser
WY
$18.2B
| $201K | 0.03% |
+6,680
| New | +$206K |
|
153
Sprott Physical Gold and Silver Trust
CEF
$8.3B
| $192K | 0.03% |
17,000
| – | – |
|
|
FNM
154
DELISTED
FANNIE MAE
FNM
| $117K | 0.02% |
30,000
| – | – |
|
155
Old Second Bancorp
OSBC
$1.29B
| $110K | 0.01% |
10,000
| – | – |
|
156
Alcoa
AA
$13.6B
| – | – |
-9,988
| Closed | -$243K |
|
|
157
Arthur J. Gallagher & Co
AJG
$64.7B
| – | – |
-7,615
| Closed | -$387K |
|
158
Franklin Resources
BEN
$17B
| – | – |
-7,400
| Closed | -$263K |
|
159
iShares MSCI Emerging Markets ETF
EEM
$29.8B
| – | – |
-5,985
| Closed | -$224K |
|
160
Teva Pharmaceuticals
TEVA
$42.1B
| – | – |
-6,017
| Closed | -$277K |
|
Similar funds
CB
LC
HA
CI
CW
SIM
HCM
CAM
Lodestar Investment Counsel's Q4 2016 Portfolio in Review
As of Q4 2016, Lodestar Investment Counsel held 162 positions worth $739M, up 1.7% from $727M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Lodestar Investment Counsel's Q4 2016 filing shows 4 new, 51 increased, 65 reduced and 5 closed positions. Its largest new stake was iShares MSCI KLD 400 Social ETF: 6,286 shares worth $259K. The largest sale was CVS Health, an estimated $5.71M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 17% a quarter earlier, followed by Financials and Industrials.
- Lodestar Investment Counsel's largest Q4 2016 buy was iShares MSCI KLD 400 Social ETF: 6,286 shares worth $259K.
- Lodestar Investment Counsel added most to Thermo Fisher Scientific in Q4 2016, an estimated $1.26M increase.
- Lodestar Investment Counsel's biggest Q4 2016 reduction was CVS Health, cutting an estimated $5.71M.
- Lodestar Investment Counsel fully exited Arthur J. Gallagher & Co in Q4 2016, selling an estimated $387K.
- Lodestar Investment Counsel's ten largest holdings make up 30% of its $739M portfolio in Q4 2016.
- Lodestar Investment Counsel opened 4 new positions and closed 5 in Q4 2016.
- Lodestar Investment Counsel's portfolio value rose 1.7% quarter-over-quarter to $739M.
Based on Lodestar Investment Counsel's 13F filing for Q4 2016, filed 23 Jan 2017.